Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06250751 · ClinicalTrials.gov registry record · NA

Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca

A NA study of Prostate Cancer, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT06250751: Completed NA study of Prostate Cancer, sponsored by Virginia Commonwealth University.

NCT06250751 is a NA study of Prostate Cancer that has completed, run by Virginia Commonwealth University. The registered enrollment target is 27 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06250751, a NA study of Prostate Cancer, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

To refine a remote behavioral exercise training intervention for testing in a larger randomized trial.

Primary Outcome

The number of participants that enroll

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Exercise Training (BET) intervention

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2024-02-05
Est. Completion 2025-10-06
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT06250751 record still lists

NCT06250751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Exercise Training (BET) intervention is the first listed.

NCT06250751 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06250751 about?

NCT06250751 is a clinical study titled "Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca". To refine a remote behavioral exercise training intervention for testing in a larger randomized trial.

What is the current status of trial NCT06250751?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2024-02-05. Estimated completion is 2025-10-06.

What conditions does trial NCT06250751 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06250751?

The interventions under investigation include: Behavioral Exercise Training (BET) intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06250751?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06250751 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06250751's enrollment target sits among peer trials

27 615th of 735 higher than 114 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06250751, the US trial registry maintained by the National Library of Medicine. NCT06250751 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.